Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease

NCT03499639 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

End-stage Renal Disease
HCV Coinfection

Interventions

DRUG: Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet

Sponsor

Assiut University

Collaborators

[object Object]
[object Object]